ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Austin, TX, USA:

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Evaluate the safety and tolerability of RMC-6236 in adults with specific RAS mutant advanced solid tumors....

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: RMC-6236

Phase 1

Revolution Medicines
Revolution Medicines

Austin, Texas, United States and 14 other locations

dose-escalation, safety, pharmacokinetics (PK), and biomarker study of CBX-12 in subjects with advanced or metastatic refractory solid tumors...

Active, not recruiting
Esophagus Cancer
Breast Cancer
Drug: CBX-12

Phase 1, Phase 2

Cybrexa Therapeutics

Austin, Texas, United States and 3 other locations

of care. It is being tested against advanced and/or metastatic solid tumors including gastric, gastroesophageal junction, pancreatic...

Enrolling
Advanced Cancer
Gastric Cancer
Drug: mFOLFOX6
Drug: Gemcitabine

Phase 1, Phase 2

Transcenta

Austin, Texas, United States and 18 other locations

as PK and pharmacodynamics of XL309 (previously ISM3091) administered alone or in combination with olaparib in subjects with advanced solid tumors...

Enrolling
Advanced Solid Tumor
Drug: Olaparib
Drug: XL309 (ISM3091)

Phase 1

Exelixis
Exelixis

Austin, Texas, United States and 11 other locations

This is a Phase 2, multicenter, open-label, 3-arm, randomized, parallel group study to evaluate the efficacy and safety of TTX-030 with or without bu...

Enrolling
Pancreatic Cancer
Combination Product: TTX-030, nab-paclitaxel and gemcitabine
Combination Product: TTX-030, budigalimab, nab-paclitaxel and gemcitabine

Phase 2

Trishula Therapeutics

Austin, Texas, United States and 67 other locations

Study of NGM831 as Monotherapy and in Combination with Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors...

Enrolling
Breast Cancer
Esophageal Cancer
Drug: NGM831
Drug: NGM831 plus pembrolizumab (KEYTRUDA®)

Phase 1

NGM Biopharmaceuticals

Austin, Texas, United States and 8 other locations

liposome injection in combination with other approved drugs used for cancer therapy, namely 5 fluorouracil/leucovorin (5FU/LV) plus oxalipla ...

Active, not recruiting
Metastatic Adenocarcinoma of the Pancreas
Drug: Leucovorin
Drug: Gemcitabine

Phase 3

Ipsen
Ipsen

Austin, Texas, United States and 199 other locations

and clinical antitumor activity of XB002 administered IV q3w alone and in combination with nivolumab to subjects with advanced solid tumors....

Active, not recruiting
Endometrial Cancer
Tissue Factor-Expressing Solid Tumors
Drug: XB002
Drug: Nivolumab

Phase 1

Exelixis
Exelixis

Austin, Texas, United States and 94 other locations

evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 (adagrasib) in patients with advanced solid tumors...

Enrolling
Metastatic Cancer
Advanced Cancer
Drug: Cetuximab
Drug: Afatinib

Phase 1, Phase 2

Mirati Therapeutics
Mirati Therapeutics

Austin, Texas, United States and 219 other locations

to explore CAIX expression through 89Zirconium-labelled girentuximab deferoxamine (89Zr-girentuximab) PET/CT imaging in patients with solid tumors...

Enrolling
Epithelial Ovarian Cancer
Esophageal Cancer
Drug: 89Zr-DFO-girentuximab

Phase 2

Telix Pharmaceuticals

Austin, Texas, United States and 4 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems